I subsidiary corporation Guang Sheng Medicine to apply for new three board

1435659138273337.jpg

1435659144980350.jpg

The Meihua Biont, (600873) late announcement on April 24, a wholly owned subsidiary company of Lhasa holding subsidiary of Meihua Guang Sheng Medicine to apply for stock transfer system of small and medium-sized enterprises in the country(hereinafter referred to as "new three board") cartellino. In addition, wide Guang Sheng medicine proposed increase endowment spread, the Meihua in Lhasa offered $46.2 million to subscribe raw medicine 1.3356 million shares. Before the capital increase, the Meihua in Lhasa holds a 51.761% stake in wide Guang Sheng medicine. After the completion of the capital increase, the Meihua in Lhasa will hold a 50.1342% stake in wide Guang Sheng medicine, is still widely raw medicine's controlling shareholder.

News contact

Service hotline:400-960-0873

Group the switchboard:+86 316-2359999

Email:meihua@meihuagrp.com

Client inquiry|Webs of subsidiary members|Contact Us|Legal Statement|Privacy Protection

Focusing on Biotechnology, Building and Sharing Better Future

CopyRight @ 2005 MEIHUA HOLDINGS GROUP CO., LTD .

  • WeChat

  • Mobile

Contact Us

MEIHUA HOLDINGS GROUP CO., LTD.

Registered address: Kim Lhasa Tibet autonomous region west road no. 189

Office address: No.66 Huaxiang Road,Economic and Technical Development Area,Langfang City, Hebei Province 065001, China

The service hotline: 400-960-0873

Tel: +86 316-2359999 Fax: +86 316-2359679

Email:meihua@meihuagrp.com

URL:www.meihuagrp.com